STAT+: With $173 million, newly introduced startup takes aim at sickle cell
🌐 Source: Statnews • 📅 17 Nov 2026 • ⏱️ 1 min read (18 words, ⚡ Quick Read)
STAT Plus: Sellas’ experimental blood cancer immunotherapy reduced risk of death in clinical trial
→ Read original article